224 related articles for article (PubMed ID: 38828226)
1. Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis.
Turizo MJF; Patell R; Zwicker JI
Bleeding Thromb Vasc Biol; 2024; 3(Suppl 1):. PubMed ID: 38828226
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel plasma biomarkers for future incident venous thromboembolism by untargeted synchronous precursor selection mass spectrometry proteomics.
Jensen SB; Hindberg K; Solomon T; Smith EN; Lapek JD; Gonzalez DJ; Latysheva N; Frazer KA; Braekkan SK; Hansen JB
J Thromb Haemost; 2018 Sep; 16(9):1763-1774. PubMed ID: 29964323
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipopolysaccharide-binding protein is a biomarker for future venous thromboembolism: Results from discovery and validation studies.
Jensen SB; Latysheva N; Hindberg K; Ueland T
J Intern Med; 2022 Sep; 292(3):523-535. PubMed ID: 35426199
[TBL] [Abstract][Full Text] [Related]
4. Proteomics in thrombosis research.
Edfors F; Iglesias MJ; Butler LM; Odeberg J
Res Pract Thromb Haemost; 2022 Mar; 6(3):e12706. PubMed ID: 35494505
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs as prognostic biomarkers for (cancer-associated) venous thromboembolism.
Anijs RJS; Nguyen YN; Cannegieter SC; Versteeg HH; Buijs JT
J Thromb Haemost; 2023 Jan; 21(1):7-17. PubMed ID: 36695398
[TBL] [Abstract][Full Text] [Related]
6. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC
PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832
[TBL] [Abstract][Full Text] [Related]
7. PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study.
Bruzelius M; Iglesias MJ; Hong MG; Sanchez-Rivera L; Gyorgy B; Souto JC; Frånberg M; Fredolini C; Strawbridge RJ; Holmström M; Hamsten A; Uhlén M; Silveira A; Soria JM; Smadja DM; Butler LM; Schwenk JM; Morange PE; Trégouët DA; Odeberg J
Blood; 2016 Dec; 128(23):e59-e66. PubMed ID: 27742707
[TBL] [Abstract][Full Text] [Related]
8. Identification of thrombotic biomarkers in orthopedic surgery patients by plasma proteomics.
Liu CQ; Gao YJ; Lin GX; Liang JZ; Li YF; Wang YC; Chen WY; Chen WJ
J Orthop Surg Res; 2023 Mar; 18(1):222. PubMed ID: 36944974
[TBL] [Abstract][Full Text] [Related]
9. The combination of Caprini risk assessment scale and thrombotic biomarkers to evaluate the risk of venous thromboembolism in critically ill patients.
Fu Y; Liu Y; Chen S; Jin Y; Jiang H
Medicine (Baltimore); 2018 Nov; 97(47):e13232. PubMed ID: 30461624
[TBL] [Abstract][Full Text] [Related]
10. Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer.
Glassman D; Bateman NW; Lee S; Zhao L; Yao J; Tan Y; Ivan C; Rangel KM; Zhang J; Conrads KA; Hood BL; Abulez T; Futreal PA; Fleming ND; Afshar-Kharghan V; Maxwell GL; Conrads TP; Chen K; Sood AK
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326647
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS).
Königsbrügge O; Pabinger I; Ay C
Thromb Res; 2014 May; 133 Suppl 2():S39-43. PubMed ID: 24862144
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers and the post-thrombotic syndrome: A systematic review of biomarkers associated with the occurrence of the post-thrombotic syndrome after lower extremity deep venous thrombosis.
Harbsmeier AN; Altintas I; Iversen K; Andersen O; Nehlin JO
Phlebology; 2023 Oct; 38(9):577-598. PubMed ID: 37620994
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory biomarkers in deep venous thrombosis organization, resolution, and post-thrombotic syndrome.
Audu CO; Gordon AE; Obi AT; Wakefield TW; Henke PK
J Vasc Surg Venous Lymphat Disord; 2020 Mar; 8(2):299-305. PubMed ID: 32067731
[TBL] [Abstract][Full Text] [Related]
15. D-dimer at venous thrombosis diagnosis is associated with risk of recurrence.
Bjøri E; Johnsen HS; Hansen JB; Braekkan SK
J Thromb Haemost; 2017 May; 15(5):917-924. PubMed ID: 28166605
[TBL] [Abstract][Full Text] [Related]
16. [Estimation of venous thromboembolism risk with thrombotic biomarkers in cancer patients].
Jianlong M; Diansheng Z; Jing R
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):283-9. PubMed ID: 26462893
[TBL] [Abstract][Full Text] [Related]
17. Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients.
Ay C; Pabinger I
Thromb Res; 2012 Apr; 129 Suppl 1():S6-9. PubMed ID: 22682135
[TBL] [Abstract][Full Text] [Related]
18. Markers of coagulation activation, inflammation and fibrinolysis as predictors of poor outcomes after pediatric venous thromboembolism: A systematic review and meta-analysis.
Zia A; Russell J; Sarode R; Veeram SR; Josephs S; Malone K; Zhang S; Journeycake J
Thromb Res; 2017 Dec; 160():1-8. PubMed ID: 29078111
[TBL] [Abstract][Full Text] [Related]
19. Acute venous thromboembolism plasma and red blood cell metabolomic profiling reveals potential new early diagnostic biomarkers: observational clinical study.
Febra C; Saraiva J; Vaz F; Macedo J; Al-Hroub HM; Semreen MH; Maio R; Gil V; Soares N; Penque D
J Transl Med; 2024 Feb; 22(1):200. PubMed ID: 38402378
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of biomarkers among hospitalized patients with COVID-19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTH.
Woller SC; de Wit K; Robert-Ebadi H; Masias C; Klok FA; den Exter PL; Morange PE; Castelli D; Hansen JB
Res Pract Thromb Haemost; 2022 Aug; 6(6):e12786. PubMed ID: 36032214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
